<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-20301" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Deep Venous Thrombosis of the Lower Extremity</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Schick</surname>
            <given-names>Michael A.</given-names>
          </name>
          <aff>UC Davis Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Pacifico</surname>
            <given-names>Luigi</given-names>
          </name>
          <aff>Un of MA Med School, MA College of Phar</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Michael Schick declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Luigi Pacifico declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>26</day>
          <month>9</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-20301.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>A deep-vein thrombosis (DVT) is a blood clot that forms within the deep veins, usually of the leg, but can occur in the arms and the mesenteric and cerebral veins. Deep-vein thrombosis is a common and important disease. It is part of the venous thromboembolism disorders, which represent the third most common cause of death from cardiovascular disease after heart attacks and stroke. Even in patients who do not get pulmonary emboli, recurrent thrombosis and "post-thrombotic syndrome" are a major cause of morbidity. This activity reviews the etiology, presentation, evaluation, and management of deep vein thrombosis and reviews the role of the interprofessional team in evaluating, diagnosing, and managing the condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Determine&#x000a0;the etiology and pathophysiology of deep vein thrombosis.</p></list-item><list-item><p>Identify&#x000a0;the patient risk factors and potential preventative strategies for DVT.</p></list-item><list-item><p>Compare&#x000a0;the treatment and management options for a patient with deep vein thrombosis.</p></list-item><list-item><p>Communicate&#x000a0;possible interprofessional team strategies for improving care coordination and communication to advance the evaluation and treatment of deep vein thrombosis and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20301&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20301">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-20301.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Deep Vein Thrombosis (DVT) is a major cause of morbidity and mortality, and sequelae range&#x000a0;from venous stasis to pulmonary embolism (PE). DVT occurs when a thrombus (thrombus) forms in&#x000a0;1 of the body's deep veins. See <bold>Image</bold>.&#x000a0;Deep Vein Thrombosis (DVT).</p>
      </sec>
      <sec id="article-20301.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Virchow's&#x000a0;triad of venous stasis or turbulence, coagulopathy, and endothelial injury highlight the major risk factors for developing a DVT. Other known and common risk factors include malignancy, recent surgery, immobilization, estrogen therapy, especially when combined with tobacco abuse, a history of previous DVT or PE, and strong family history.<xref ref-type="bibr" rid="article-20301.r1">[1]</xref><xref ref-type="bibr" rid="article-20301.r2">[2]</xref><xref ref-type="bibr" rid="article-20301.r3">[3]</xref><xref ref-type="bibr" rid="article-20301.r4">[4]</xref><xref ref-type="bibr" rid="article-20301.r3">[3]</xref></p>
      </sec>
      <sec id="article-20301.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>DVT is a common problem in primary care, acute care, and inpatient settings. It&#x000a0;is not clear what the actual incidence is, but DVT is found in about 80 out of 100,000 cases. One out of 20 people develops a DVT sometime during their lifetime. DVTs account for approximately 600,000 hospitalizations per year in the United States. DVTs occur more commonly in those older than 40 years old. There is an increased incidence in the male and African American populations.</p>
      </sec>
      <sec id="article-20301.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Venous stasis, endothelial damage, or inflammation are typically present and lead to a hypercoagulable state. Activation of the clotting cascade and aggregation of platelets and blood cells occurs simultaneously to form a thrombus. The thrombus can cause complete or partial vein occlusion, leading to venous stasis, lymphedema, and possibly ischemia to surrounding tissue. A DVT can propagate and lead to PE.</p>
      </sec>
      <sec id="article-20301.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Specific historical features that assist in the diagnosis of a DVT are those related to DVT risk factors and include a history of cancer, exogenous estrogen therapy, recent surgery, smoking tobacco, previous history of DVT, immobility, age, history of a hypercoagulable state, and other comorbidities. Patients&#x000a0;often present with a chief complaint of unilateral leg swelling and discomfort. Be mindful to ask about symptoms related to a PE, such as chest pain, shortness of breath, and syncope. The physical exam most commonly demonstrates unilateral extremity swelling, warmth and discomfort over the vein, and, perhaps, a palpable "cord" where the DVT is located.</p>
      </sec>
      <sec id="article-20301.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Clinical decision rules such as the&#x000a0;Pulmonary Embolism Rule-Out Criteria (PERC)&#x000a0;and the Wells Criteria should be employed when the patient presents with a possible DVT. Risk stratification is crucial in deciding diagnostic and management options. Patients who meet PERC criteria may need no further testing. In contrast, those who do not meet PERC criteria and are low probability based on the Wells Criteria may be candidates for rule-out with a D-dimer. The D-dimer test is sensitive but not specific. It should be used selectively in low-probability patients who do not have other confounding diagnoses that could produce a false positive test. The test should also be used cautiously, with different cut-off values for the elderly.<xref ref-type="bibr" rid="article-20301.r5">[5]</xref><xref ref-type="bibr" rid="article-20301.r6">[6]</xref><xref ref-type="bibr" rid="article-20301.r7">[7]</xref><xref ref-type="bibr" rid="article-20301.r8">[8]</xref></p>
        <p>Imaging modalities for DVT evaluation include diagnostic ultrasound, vascular studies, CT venograms, and point-of-care ultrasound (POCUS). The POCUS exam is described below.</p>
        <p>Rapid diagnosis or rule-out by the emergency provider can expedite necessary treatment, reduce the length of stay, and is particularly useful where access to 24-hour ultrasound is unavailable. There is evidence that emergency practitioners can perform a 2-point compression exam at the&#x000a0;2 highest probability sites for identifying a DVT: femoral and popliteal veins. However, recent literature suggests a 2-region approach where clinicians do serial compression testing, which may greatly improve diagnostic sensitivity without increasing diagnostic time. This point-of-care ultrasound exam should be used with other clinical decision rules and is perhaps most useful in those patients with high and low pre-test probability.</p>
        <p>With the patient supine in the frog-leg position, approximately 20 to 30 degrees of reverse Trendelenburg is applied to increase venous distention. Place the high-frequency linear transducer (5 to 10 MHz) in the transverse plane at the anatomical location of the inguinal ligament. The common femoral vein can be visualized just distal to the inguinal ligament. Apply direct pressure to the vein. The complete collapse of the vein indicates there is no presence of a DVT. Continue distally along the femoral vein to where the greater saphenous and deep femoral veins deviate from the common femoral veins. Compression of all venous structures at these levels rules out a proximal DVT.</p>
        <p>Next, proceed to the popliteal region. Laterally rotate the leg, flex the knee, and place the high-frequency transducer transversely in the popliteal fossa. The popliteal vein typically resides just anterior to the popliteal artery. Apply a compressive force once again and observe for complete compression. Compress the proximal and distal areas to the popliteal fossa to complete the 2-region technique. See <bold>Video.</bold> Popliteal Deep Vein Thrombosis (DVT) With Partial Color Flow.&#x000a0;</p>
        <p>If DVT studies are negative, repeat testing may be required in&#x000a0;1 to&#x000a0;2 weeks to rule out a propagating calf DVT further. Alternatively, sending a D-dimer test may be adequate in certain patient populations. Typical laboratory tests&#x000a0;also&#x000a0;should be sent to evaluate for coagulation status, blood count, and renal function.<xref ref-type="bibr" rid="article-20301.r9">[9]</xref><xref ref-type="bibr" rid="article-20301.r10">[10]</xref></p>
      </sec>
      <sec id="article-20301.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>There are many options available to manage DVT. The first decision that should be made is whether the patient requires hospital admission or can be discharged on anticoagulation. This complex decision depends on many factors, including patient adherence to medication, insurance issues, the reliability of follow-up, renal function, comorbidities, concomitant medications, the risk of falling, and how ill the patient appears. The traditional treatment option is to use heparin or low-molecular-weight heparin and bridge to warfarin therapy. This often requires hospital admission, but it may be managed as an outpatient in some healthcare settings. New anticoagulants such as direct antithrombin inhibitors are also options, but the use of these medications must be made on an individual basis.</p>
        <p>Inferior vena cava (IVC) filters have been used historically to avoid the propagation of DVTs in the pulmonary artery. Based on current literature, it is unclear if IVC filters prevent PEs, and therefore, they are falling out of favor. However, they may still be indicated in specific clinical situations.</p>
      </sec>
      <sec id="article-20301.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnoses for deep venous thrombosis of the lower extremity include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Baker cyst imaging</p>
          </list-item>
          <list-item>
            <p>Budd-Chiari syndrome imaging</p>
          </list-item>
          <list-item>
            <p>Cellulitis</p>
          </list-item>
          <list-item>
            <p>Dependent oedema</p>
          </list-item>
          <list-item>
            <p>Heart failure</p>
          </list-item>
          <list-item>
            <p>Hepatic disease</p>
          </list-item>
          <list-item>
            <p>Pulmonary embolism</p>
          </list-item>
          <list-item>
            <p>Renal failure</p>
          </list-item>
          <list-item>
            <p>Septic thrombophlebitis</p>
          </list-item>
          <list-item>
            <p>Nephritic syndrome</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20301.s10" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>The 2-region ultrasound examination commonly misses calf DVTs. Complete compression of the veins is the only measure that rules out DVTs. Doppler and color may be used but are not necessary for this evaluation. This safe and rapid exam does not lead to DVT propagation.</p>
      </sec>
      <sec id="article-20301.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Deep vein thrombosis is a common occurrence in hospitalized patients. The condition has no specific signs and symptoms, and to prevent high morbidity and mortality, it is best managed by an interprofessional team that consists of a nurse practitioner, hematologist, internist, and pharmacist. Prompt diagnosis and treatment are key. There are many treatment options today, but some anticoagulation therapy is required. The condition is best treated by prophylaxis with unfractionated heparin or LMWH. Compression stockings and early mobility after surgery are essential. For those treated promptly, the outlook is good, but postphlebitic&#x000a0;syndrome is known to occur in a significant number of patients.<xref ref-type="bibr" rid="article-20301.r11">[11]</xref><xref ref-type="bibr" rid="article-20301.r12">[12]</xref></p>
      </sec>
      <sec id="article-20301.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20301&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20301">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/deep-venous-thrombosis-of-the-lower-extremity-dvt-of-the-leg/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=20301">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/20301/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=20301">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-20301.s13">
        <fig id="article-20301.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Deep Vein Thrombosis. This illustration compares normal blood flow with that of deep vein thrombosis and embolism within the deep veins of the leg. Contributed by M Schick, DO</p>
          </caption>
          <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="dvt__femoral__and__saphenous__with__partial__flow-2-2.mp4" mime-subtype="mp4" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-20301.s14">
        <fig id="article-20301.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Deep Vein Thrombosis. This illustration compares normal blood flow with that of deep vein thrombosis and embolism within the deep veins of the leg. (https://creativecommons.org/licenses/by-nd/2.0/deed.en)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="DVT" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-20301.s15">
        <title>References</title>
        <ref id="article-20301.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brand&#x000e3;o</surname>
                <given-names>GMS</given-names>
              </name>
              <name>
                <surname>C&#x000e2;ndido</surname>
                <given-names>RCF</given-names>
              </name>
              <name>
                <surname>Rollo</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Sobreira</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Junqueira</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Direct oral anticoagulants for treatment of deep vein thrombosis: overview of systematic reviews.</article-title>
            <source>J Vasc Bras</source>
            <year>2018</year>
            <season>Oct-Dec</season>
            <volume>17</volume>
            <issue>4</issue>
            <fpage>310</fpage>
            <page-range>310-317</page-range>
            <pub-id pub-id-type="pmid">30787949</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20301.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jara-Palomares</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>van Es</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Praena-Fernandez</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Le Gal</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Otten</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Robin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Piccioli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lecumberri</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Religa</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rieu</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Rondina</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Beckers</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Prandoni</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Salaun</surname>
                <given-names>PY</given-names>
              </name>
              <name>
                <surname>Di Nisio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bossuyt</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Kraaijpoel</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>B&#x000fc;ller</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Carrier</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Relationship between type of unprovoked venous thromboembolism and cancer location: An individual patient data meta-analysis.</article-title>
            <source>Thromb Res</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>176</volume>
            <fpage>79</fpage>
            <page-range>79-84</page-range>
            <pub-id pub-id-type="pmid">30780008</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20301.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Lo</surname>
                <given-names>NN</given-names>
              </name>
              <name>
                <surname>Chia</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Tay</surname>
                <given-names>KJD</given-names>
              </name>
              <name>
                <surname>Pang</surname>
                <given-names>HN</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>ESY</given-names>
              </name>
              <name>
                <surname>Yeo</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>The safest and most efficacious route of tranexamic acid administration in total joint arthroplasty: A systematic review and network meta-analysis.</article-title>
            <source>Thromb Res</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>176</volume>
            <fpage>61</fpage>
            <page-range>61-66</page-range>
            <pub-id pub-id-type="pmid">30776688</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20301.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ye</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>The Diagnostic Efficacy of Age-Adjusted D-Dimer Cutoff Value and Pretest Probability Scores for Deep Venous Thrombosis.</article-title>
            <source>Clin Appl Thromb Hemost</source>
            <year>2019</year>
            <season>Jan-Dec</season>
            <volume>25</volume>
            <fpage>1076029619826317</fpage>
            <pub-id pub-id-type="pmid">30754991</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20301.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tran</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Gibbs</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Merriman</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Curnow</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Chunilal</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nandurkar</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>New guidelines from the Thrombosis and Haemostasis Society of Australia and New Zealand for the diagnosis and management of venous thromboembolism.</article-title>
            <source>Med J Aust</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>210</volume>
            <issue>5</issue>
            <fpage>227</fpage>
            <page-range>227-235</page-range>
            <pub-id pub-id-type="pmid">30739331</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20301.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coolidge</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Development of a Pharmacologic Venous Thromboembolism Protocol for Trauma Patients.</article-title>
            <source>S D Med</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>71</volume>
            <issue>10</issue>
            <fpage>438</fpage>
            <page-range>438-444</page-range>
            <pub-id pub-id-type="pmid">30731517</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20301.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alyea</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gaston</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Austin</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Wowkanech</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cypel</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Pontes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>The Effectiveness of Aspirin for Venous Thromboembolism Prophylaxis for Patients Undergoing Arthroscopic Rotator Cuff Repair.</article-title>
            <source>Orthopedics</source>
            <year>2019</year>
            <month>Mar</month>
            <day>01</day>
            <volume>42</volume>
            <issue>2</issue>
            <fpage>e187</fpage>
            <page-range>e187-e192</page-range>
            <pub-id pub-id-type="pmid">30602049</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20301.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Deep Vein Thrombosis Prophylaxis after Total Hip Arthroplasty in Asian Patients.</article-title>
            <source>Hip Pelvis</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>30</volume>
            <issue>4</issue>
            <fpage>197</fpage>
            <page-range>197-201</page-range>
            <pub-id pub-id-type="pmid">30534537</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20301.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ohmori</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kanaoka</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yamasaki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Takesue</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sumimoto</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and Characteristic Features of Deep Venous Thrombosis in Patients with Severe Motor and Intellectual Disabilities.</article-title>
            <source>Ann Vasc Dis</source>
            <year>2018</year>
            <month>Sep</month>
            <day>25</day>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>281</fpage>
            <page-range>281-285</page-range>
            <pub-id pub-id-type="pmid">30402176</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20301.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tritschler</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kraaijpoel</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Le Gal</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wells</surname>
                <given-names>PS</given-names>
              </name>
            </person-group>
            <article-title>Venous Thromboembolism: Advances in Diagnosis and Treatment.</article-title>
            <source>JAMA</source>
            <year>2018</year>
            <month>Oct</month>
            <day>16</day>
            <volume>320</volume>
            <issue>15</issue>
            <fpage>1583</fpage>
            <page-range>1583-1594</page-range>
            <pub-id pub-id-type="pmid">30326130</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20301.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>L&#x000f3;pez-N&#x000fa;&#x000f1;ez</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Trujillo-Santos</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Monreal</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Management of venous thromboembolism in patients with&#x000a0;cancer.</article-title>
            <source>J Thromb Haemost</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>16</volume>
            <issue>12</issue>
            <fpage>2391</fpage>
            <page-range>2391-2396</page-range>
            <pub-id pub-id-type="pmid">30246407</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20301.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Milinis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shalhoub</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Coupland</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Salciccioli</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Thapar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <article-title>The effectiveness of graduated compression stockings for prevention of venous thromboembolism in orthopedic and abdominal surgery patients requiring extended pharmacologic thromboprophylaxis.</article-title>
            <source>J Vasc Surg Venous Lymphat Disord</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>6</volume>
            <issue>6</issue>
            <fpage>766</fpage>
            <page-range>766-777.e2</page-range>
            <pub-id pub-id-type="pmid">30126797</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
